Loading...
Loading...
Application UK00914907968 · Expired
| Application Number | UK00914907968 |
| Status | Expired |
| Owner | Bayer Intellectual Property GmbH |
| Filed | 2015-12-15 |
| Registered | 2016-04-19 |
| Renewal Due | 2025-12-15 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
ARNUVIDAS has a current status of Expired.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical preparations, pharmaceutical preparations for the treatment of cancer, none of these products in the field of diagnosis.
Medical apparatus and instruments, inhaling and atomizing drug delivery apparatus for medical purposes, none of these products in the field of diagnosis.
'ARNUVIDAS' is a expired trademark on the UK IPO register, owned by Bayer Intellectual Property GmbH. The application (UK00914907968) was filed on 15 December 2015 and registered on 19 April 2016. The registration is set to expire on 15 December 2025.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 10 (medical & surgical apparatus).
The trademark is represented by Abel & Imray LLP.
UK trademark UK00914907968 for the mark 'ARNUVIDAS' in Class 5, 10 is recorded on the UK IPO register as owned by Bayer Intellectual Property GmbH. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
No — the UK IPO records the status of UK trademark UK00914907968 for the mark 'ARNUVIDAS' as expired.
UK trademark UK00914907968 for the mark 'ARNUVIDAS' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 10 (medical & surgical apparatus). The filed specification reads: Class 5: Pharmaceutical preparations, pharmaceutical preparations for the treatment of cancer, none of these products in the field of diagnosis. | Class 10: Medical apparatus and instruments, inhaling and atomizing drug delivery apparatus for medical purposes, none of these products in the field of diagnosis.
UK trademark UK00914907968 for the mark 'ARNUVIDAS' was filed at the UK IPO on 15 December 2015 and registered on 19 April 2016.
UK trademark UK00914907968 for the mark 'ARNUVIDAS' is currently recorded as valid until 15 December 2025, at which point it will need to be renewed with the UK IPO to remain in force.
Abel & Imray LLP is listed as the attorney / representative of record for UK trademark UK00914907968 for the mark 'ARNUVIDAS' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "ARNUVIDAS" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| ARNUVIDASSame applicant | 87067480 | 710 | 2016-06-10 |
| Mark | Ref | Status | Filed |
|---|---|---|---|
| ARNUVIDASSame applicant | 1792114 | protected | 2016-08-25 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
Australian trademark data is supplied by IP Australia (via IPGOD / IP RAPID) under the Creative Commons Attribution 4.0 International licence.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.